Ascendis Pharma A (ASND) Intangibles (2020 - 2026)

Ascendis Pharma A (ASND) has 7 years of Intangibles data on file, last reported at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles changed N/A year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (changed N/A YoY), and the FY2025 full-year result was $4.3 million, down 0.94% from the prior year.
• Intangibles was little changed at $4.3 million in Q1 2026, from $4.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $5.8 million in Q4 2022 to a low of $3.8 million in Q4 2023.
• A 5-year average of $4.5 million and a median of $4.3 million in 2025 frame the typical range for Intangibles.
• Across the five-year window, Intangibles surged 45.89% in 2022 and tumbled 35.53% in 2023, its largest moves.
• Tracing ASND's Intangibles over 5 years: stood at $5.8 million in 2022, then plunged by 35.53% to $3.8 million in 2023, then increased by 14.46% to $4.3 million in 2024, then gained by 0.33% to $4.3 million in 2025, then grew by 0.01% to $4.3 million in 2026.
• Business Quant data shows ASND's Intangibles at $4.3 million in Q1 2026, $4.3 million in Q4 2025, and $4.3 million in Q4 2024.